cyc 202 has been researched along with h 1152 in 2 studies
Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (h 1152) | Trials (h 1152) | Recent Studies (post-2010) (h 1152) |
---|---|---|---|---|---|
979 | 7 | 393 | 10 | 0 | 4 |
Protein | Taxonomy | cyc 202 (IC50) | h 1152 (IC50) |
---|---|---|---|
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | Bos taurus (cattle) | 0.1035 | |
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | Bos taurus (cattle) | 0.1035 | |
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | Bos taurus (cattle) | 0.1035 | |
Chain I, cAMP-dependent protein kinase inhibitor alpha | synthetic construct | 0.1035 | |
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | Bos taurus (cattle) | 0.1035 | |
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | Bos taurus (cattle) | 0.1035 | |
Chain I, cAMP-dependent protein kinase inhibitor alpha | synthetic construct | 0.1035 | |
Rho-associated protein kinase 2 | Homo sapiens (human) | 0.0097 | |
cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | 0.3254 | |
Rho-associated protein kinase 1 | Homo sapiens (human) | 0.005 | |
Rho-associated protein kinase 2 | Bos taurus (cattle) | 0.3254 | |
Leucine-rich repeat serine/threonine-protein kinase 2 | Homo sapiens (human) | 0.244 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
2 other study(ies) available for cyc 202 and h 1152
Article | Year |
---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |